Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study (Q37368689)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2000

Language	Label	Description	Also known as
English	Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study	scientific article published on December 2000

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study (English)

1 reference

Europe PubMed Central

20 August 2017

arterial hypertension

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

C E Mogensen

1

1 reference

Europe PubMed Central

20 August 2017

S Neldam

2

1 reference

Europe PubMed Central

20 August 2017

I Tikkanen

3

1 reference

Europe PubMed Central

20 August 2017

S Oren

4

1 reference

Europe PubMed Central

20 August 2017

R Viskoper

5

1 reference

Europe PubMed Central

20 August 2017

R W Watts

6

1 reference

Europe PubMed Central

20 August 2017

M E Cooper

7

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

321

1 reference

Europe PubMed Central

20 August 2017

1440-1444

1 reference

Europe PubMed Central

20 August 2017

7274

1 reference

Europe PubMed Central

20 August 2017

Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

6 September 2017

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

6 September 2017

British Hypertension Society guidelines for hypertension management 1999: summary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

6 September 2017

Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

6 September 2017

Nephropathy in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

6 September 2017

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

6 September 2017

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

6 September 2017

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

6 September 2017

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

14 September 2017

Angiotensin receptor antagonists: focus on losartan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

14 September 2017

Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

26 June 2018

Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

26 June 2018

Pathogenesis, prevention, and treatment of diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

2 September 2018

Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27545

2 September 2018

Angiotensin-converting enzyme genotype in children and coronary events in their grandparents

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive effects of losartan and enalapril on blood pressure and plasma active renin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Candesartan cilexetil. A review of its use in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11110735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.321.7274.1440

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37368689&oldid=1909630637"